Find stats on top websites
Mahana Therapeutics targets two main groups: 1) Patients suffering from chronic conditions, specifically IBS and tinnitus. 2) Healthcare providers such as Gastroenterologists, Hearing Healthcare Providers, Psychologists, and Registered Dietitians, aiming to equip them with innovative tools to improve patient outcomes.
Mahana Therapeutics' primary market is the US, followed by the UK. Their services are likely expanding to other English-speaking and European countries.
United States
United Kingdom
Canada
Australia
Germany
Primary age group concentration shows strong presence in:
31-35
Most active age range
The target users are primarily from households of 2-4 people, indicating adults living with families or partners, and mostly fall within the middle-income range.
Sign up now and unleash the power of AI for your business growth